These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 3566249)
1. Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Giuliano M; Barza M; Jacobus NV; Gorbach SL Antimicrob Agents Chemother; 1987 Feb; 31(2):202-6. PubMed ID: 3566249 [TBL] [Abstract][Full Text] [Related]
2. Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans. Barza M; Giuliano M; Jacobus NV; Gorbach SL Antimicrob Agents Chemother; 1987 May; 31(5):723-7. PubMed ID: 3496848 [TBL] [Abstract][Full Text] [Related]
3. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. Gorbach SL; Barza M; Giuliano M; Jacobus NV Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):98-102. PubMed ID: 3132394 [TBL] [Abstract][Full Text] [Related]
4. Impact of cefoperazone therapy on fecal flora. Mulligan ME; Citron DM; McNamara BT; Finegold SM Antimicrob Agents Chemother; 1982 Aug; 22(2):226-30. PubMed ID: 6927284 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics. Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem. Neu HC; Chin NX; Saha G; Labthavikul P Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Nord CE; Heimdahl A; Kager L Scand J Infect Dis Suppl; 1986; 49():64-72. PubMed ID: 3547626 [TBL] [Abstract][Full Text] [Related]
8. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates. Greenberg RN; Bowne DB; Gelfand M; Sathe SS Clin Ther; 1990; 12(1):61-70. PubMed ID: 2183941 [TBL] [Abstract][Full Text] [Related]
9. Ecological impact of antimicrobial prophylaxis on intestinal microflora in patients undergoing colorectal surgery. Brismar B; Edlund C; Malmborg AS; Nord CE Scand J Infect Dis Suppl; 1990; 70():25-30. PubMed ID: 2287900 [TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam. Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280 [TBL] [Abstract][Full Text] [Related]
11. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains]. Mascellino MT; Prignano G; Iegri F; Lorenzi A Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234 [TBL] [Abstract][Full Text] [Related]
12. Effect of piperacillin/tazobactam therapy on intestinal microflora. Nord CE; Brismar B; Kasholm-Tengve B; Tunevall G Scand J Infect Dis; 1992; 24(2):209-13. PubMed ID: 1322559 [TBL] [Abstract][Full Text] [Related]
13. Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers. de Vries-Hospers HG; Welling GW; Swabb EA; van der Waaij D J Infect Dis; 1984 Nov; 150(5):636-42. PubMed ID: 6541674 [TBL] [Abstract][Full Text] [Related]
14. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. Barry AL; Thornsberry C; Jones RN; Gavan TL Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316 [TBL] [Abstract][Full Text] [Related]
15. [Effects of azithromycin on fecal flora of healthy adult volunteers]. Uchino U; Kanayama A; Hasegawa M; Kobayashi I; Muto H; Enogaki K; Matsunaga T; Ogawa M; Cyong JC; Kodama K Jpn J Antibiot; 1995 Sep; 48(9):1119-30. PubMed ID: 7474332 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. George WL; Lewis RP; Meyer RD Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of BRL 36650, a new penicillin. Van Landuyt HW; Lambert A; Boelaert J; Gordts B Antimicrob Agents Chemother; 1986 Feb; 29(2):362-6. PubMed ID: 3087281 [TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Stutman HR; Welch DF; Scribner RK; Marks MI Antimicrob Agents Chemother; 1984 Feb; 25(2):212-5. PubMed ID: 6538772 [TBL] [Abstract][Full Text] [Related]
19. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora. Stark C; Edlund C; Hedberg M; Nord CE Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):18-24. PubMed ID: 7729448 [TBL] [Abstract][Full Text] [Related]
20. [Effect of aztreonam on the fecal aerobic flora in children]. Borderon JC; Rastegar A; Ramponi N; Gold F; Laugier J Pathol Biol (Paris); 1987 May; 35(5):665-8. PubMed ID: 3112714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]